Search clinical trials for: very low density lipoproteins

Total 33984 results

University Hospital, Basel, Switzerland
Swiss National Science Foundation

Recruiting

Atherogenic Lipoproteins in Ischemic Stroke (AGELESS)

Ischemic Stroke

Switzerland
Hospices Civils de Lyon

Completed

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes (COMPLETE)

Type2 Diabetes

France
University of Arkansas
National Institute on Aging (NIA)

Completed

Effects of Amino Acids on Regional Lipid Metabolism

Hypertriglyceridemia

United States
The University of Texas Medical Branch, Galveston
National Institute on Aging (NIA)

Terminated

Very Low Density Lipoprotein Turnover in Young and Elderly Individuals

Aging

United States
Nutrasource Pharmaceutical and Nutraceutical Services...
University of Guelph; Biodroga Inc.

Completed

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Cardiovascular Disease

Canada
Henan Institute of Cardiovascular Epidemiology

Recruiting

Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI (EVALUATE-STEMI)

ST Elevation Myocardial Infarction (STEMI)

China
Assiut University

Not yet recruiting

Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.

SLE
Ionis Pharmaceuticals, Inc.

Recruiting

A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

Severe Hypertriglyceridemia

United States, Germany, Israel, Spain, Netherlands, Australia, Hungary, Sweden, Denmark, Canada, France, Italy, Turkey, Finland, Bulgaria, Czechia, New Zealand, Norway, Poland, Portugal, Slovakia, South Africa, United Kingdom
Universidad Veracruzana

Completed

Very Low Calorie Ketogenic Low-fat Diet (VLCKLFD) (Zelé2021)

Obesity

Mexico
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events (SANTORINI)

Cardiovascular Diseases | Dyslipidemia | Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

Finland, Netherlands, Spain, Belgium, Sweden, Austria, United Kingdom, Switzerland, Denmark, France, Germany, Portugal, Italy, Ireland
Touro University, California

Completed

Investigating the Production of Lipoproteins and Acetyl-CoA During a Ketogenic Diet (PLAK)

Cholesterol Metabolism | Ketone Metabolism

United States
University of Maryland, Baltimore
Amylin Pharmaceuticals, LLC.

Withdrawn

Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM

Type 2 Diabetes
Victor Tapson, MD
Bristol-Myers Squibb

Terminated

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism (SAFE-LYSE)

Pulmonary Embolism | Right Ventricular Dysfunction | Right Ventricular Failure | Pulmonary Embolism With Acute Cor Pulmonale | Pulmonary Embolism With Pulmonary Infarction | Pulmonary Embolism Subacute Massive

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Niacin Therapy on Lipoprotein Composition and Function

Cardiovascular Disease

United States
National Institute of Diabetes and Digestive and...
The Cleveland Clinic

Completed

The Modification of Diet in Renal Disease Study (MDRD)

Chronic Renal Disease
Wihuri Research Institute
Karolinska Institutet; University of Helsinki; Minerva Foundation Institute for...

Unknown

The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism (EPA&LDL)

Cardiovascular Diseases | Atherosclerosis | Low-density Lipoproteins Aggregation Susceptibility | Low-density Lipoprotein Lipid Composition

Finland
Second Affiliated Hospital, School of Medicine,...

Unknown

Correlation Between Plasma Oxidized Low Density Lipoprotein Levels And Postoperative Delirium

Postoperative Delirium
Asante Health System

Completed

Self Regulated Physical Activity and Bone Growth Enhancement in Premature Infants

Prematurity | VLBW - Very Low Birth Weight Infant

United States
First Affiliated Hospital Xi'an Jiaotong University
Xi'an Gaoxin Hospital

Unknown

Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants

Sepsis | Anemia | Vitamin D Deficiency | Vitamin A Deficiency | Bronchopulmonary Dysplasia | Very Low Birth Weight Infants | Vitamin E Deficiency

China
TC Erciyes University

Completed

The Effect of Daily Exercise Program on Bone Mineral Density and Cortisol Level in Preterm Infants

Osteopenia of Prematurity
Washington University School of Medicine

Completed

Sex Steroids, Sleep, and Metabolic Dysfunction in Women (SCOR)

Obesity | Obstructive Sleep Apnea | Polycystic Ovary Syndrome (PCOS)

United States
Vanderbilt University Medical Center

Terminated

Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C

Hyperlipidemia

United States
University of Aarhus

Completed

The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism

Type 2 Diabetes | Dyslipidemia

Denmark
Medical University of South Carolina
National Center for Research Resources (NCRR)

Completed

Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2

Vitamin D Deficiency | Infant, Very Low Birth Weight | Calcium Deficiency

United States
San Giuseppe Moscati Hospital

Completed

VLCD by Enteral Route for Weight Loss (NEP)

Severe Obesity

Italy
University of Aarhus

Completed

Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia

Type 1 Diabetes

Denmark
University Health Network, Toronto

Completed

Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty Acids

Insulin Resistance

Canada
Changhai Hospital

Completed

Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers

Obesity | Overweight

China
University of Leipzig

Completed

Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)

Coronary Disease | Hypolipoproteinemia

Germany
Mayo Clinic

Completed

Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)

Hypercholesterolemia

United States
University of Aarhus

Completed

Very Low Density Lipoprotein (VLDL) Triglyceride Metabolism in Exercise

Healthy

Denmark
University of Aarhus

Completed

Very-low-density-lipoprotein Triglyceride (VLDL-TG) Uptake in Visceral Fat

Healthy | Obesity

Denmark
Oregon Health and Science University
Merck Sharp & Dohme LLC; Indiana University; Oregon State University

Unknown

Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

HDL Cholesterol

United States
University of Aarhus

Completed

Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics

Obesity | Dyslipidemia

Denmark
AstraZeneca

Completed

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Dyslipidaemia
AstraZeneca

Completed

Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg (EXPLORER)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease
AstraZeneca

Completed

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks (POLARIS)

Hypercholesterolemia | Coronary Heart Disease
AstraZeneca

Completed

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) (IRIS)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

Hypercholesterolemia
AstraZeneca

Completed

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) (ARIES)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

Metabolic Syndrome
AstraZeneca

Completed

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca

Completed

Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR) (SOLAR)

Hypercholesterolemia
AstraZeneca

Completed

Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) (STARSHIP)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges (STELLAR)

Hypercholesterolemia
University of Aarhus
The Novo Nordic Foundation; The Danish Medical Research Council

Completed

Body Composition and Very-Low-Density-Lipoprotein-Triglycerides (VLDL-TG) Kinetics

Obesity | Insulin Resistance

Denmark
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Bayesian Basket Trial (PALETTE)

Sepsis
Assiut University

Not yet recruiting

Bone Mineral Density in Children With Graves' Disease

Bone Density, Low | Bone Mineral Density in Children With Graves' Disease
Washington University School of Medicine
United States Department of Defense; Aclaris Therapeutics, Inc.

Not yet recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer

United States
Durham VA Medical Center
Société des Produits Nestlé (SPN)

Not yet recruiting

The Medically Reproducing Bariatric Surgery (MRB) II Study

Obesity | Type 2 Diabetes

United States

Search clinical trials for: very low density lipoproteins

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations